Abstract
Bipolar disorder (BD) is a psychiatric disorder characterized by mood changes, ranging from mania episodes to depression (De Jesus et al. in Clin Biochem 50(18):1118–1125, 2017 [4]; Rizzo et al. in Neurosci Biobehav Rev 42:157–169, 2014 [12]). BD is a chronic, severe and recurrent disease that affects about 3% of the world population, being one of the main causes of death of patients by suicide (Belzeaux et al. in J Affect Disord 151(3):1009–1015, 2013 [1], Fulford et al. in J Affect Disord 152–154:491–497, 2014 [7]).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belzeaux R, Correard N, Boyer L, Etain B, Loffus J, Bellivier F, Bougerol T, Courtet P, Gard S, Kahn JP, Passerieux C, Leboyer M, Henry C, Azorin JM (2013) Fundamental academic centers of expertise for bipolar Disorder (FACE-BD) collaborators. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the face-bd cohort. J Affect Disord 151(3):1009–1015
Baldassano CF (2005) Assessment tools for screening and monitoring bipolar disorder. Bipolar Disord 7:8–15
Chudal R, Sourander A, Polo-Kantola P, Hinkka-Yli-Salomaki S, Lehti V, Sucksdorff D, Gissler M, Brown AS (2014) Perinatal factors and the risk of bipolar disorder in finland. J Affect Disord 155:75–80
De Jesus JR, Galazzi RM, Lima TB, Banzato CEM, Almeida Lima e Silva LF, Rosalmeida Dantas C, Gozzo FC, Arruda MAZ (2017) Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions. Clin Biochem 50(18):1118–1125
De Jesus JR, Silva Fernades R, Souza Pessôa G, Raimundo Jr IM, Arruda MAZ (2017) Depleting high-abundant and enriching low-abundant proteins in human serum: an evaluation of sample preparation methods using magnetic nanoparticle, chemical depletion and immunoaffinity techniques. Talanta 170:199–209
Fernández-Costa C, Reboiro-Jato M, Fdez-Riverola F, Ruiz-Romero C, Blanco FJ, Martínez JLC (2014) Sequential depletion coupled to C18 sequential extraction as a rapid tool for human serum multiple profiling. Talanta 125:189–195
Fulford D, Peckham AD, Johnson K, Johnson S (2014) Emotion perception and quality of life in bipolar disorder. J Affect Disord 152–154:491–497
Giusti L, Mantua V, Da Valle Y, Ciregia F, Ventroni T, Orsolini G, Donadio E, Giannaccini G, Mauri M, Cassano GB, Lucacchini A (2014) Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach. Mol Biosyst 10(6):1246–1254
Gómez-Riza AL, Morales E, Giráidez I, Sánchez-Rodas D, Valesco A (2001) Sample treatment in chromatography-based speciation of organometallic pollutants. J Chromatogr A 938(1–2):211–224
Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S (2011) Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics 11(1):94–105
Jesus JR, de Campos BK, Galazzi RM, Martinez JL, Arruda MA (2014) Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery. Anal Bioanal Chem 407:661–667
Rizzo LB, Costas LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, Mcintyre RS, Bauer ME, Brietzke E (2014) The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci Biobehav Rev 42:157–169
Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Oio C, Jelebinkov M, Kurdi Y, Ebadi M (2013) Biomarkers in parkinson’s disease (recent update). Neurochem Int 63(3):201–229
Timerbaev A, Pawlak K, Gabbiani C, Messori L (2011) Recent progress in the application of analytical techniques to anticancer metallodrug proteomics. Trends Anal Chem 30(7):1120–1138
Von thun und hohenstein-blaul N, Funke S, Grus FH (2013) Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res 117:126–137
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Jesus, J.R. (2019). Introduction. In: Proteomic and Ionomic Study for Identification of Biomarkers in Biological Fluid Samples of Patients with Psychiatric Disorders and Healthy Individuals. Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-030-29473-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-29473-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29472-4
Online ISBN: 978-3-030-29473-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)